Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript
Theriva Biologics, Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.41. Theriva Biologics, Inc.
Theriva Biologics Inc. (TOVX)
Market is closed
News
- Displaying 2
Theriva Biologics, Inc. (NYSE:TOVX) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Theriva Biologics, Inc. 2023 Third Quarter Operational Highlights and Financial Results.
Billionaire Hedge Funds
